• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Ypsomed

CGMs, insulin pumps and more: the biggest diabetes news to come out of ATTD 2022

May 3, 2022 By Sean Whooley

ATTD 2022 diabetes tech

All kinds of technologies were on display at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona last week. From continuous glucose monitoring (CGM) to automated insulin delivery, with plenty in between, a number of companies shared positive data for their diabetes offerings. Here are five of the biggest stories to come out […]

Filed Under: Auto-injectors, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: abbott, Ascensia Diabetes Care, Beta Bionics, CamDiab, dariohealth, Dexcom, Diabeloop, Insulet, Medtronic, One Drop, Tandem Diabetes Care, Walmart, welldoc, Ypsomed

Abbott, Camdiab, Ypsomed forge partnership for automated insulin delivery

April 27, 2022 By Sean Whooley

Abbott FreeStyle Libre 3 CamDiab Ypsomed ypsopump

Abbott (NYSE:ABT) announced today that it partnered with CamDiab and Ypsomed (SWX:YPSN) to produce an integrated automated insulin delivery (AID) system. The companies announced the partnership at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona, Spain. It seeks to develop and commercialize the integrated AID system with an initial focus centered around […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: abbott, CamDiab, Ypsomed

Ypsomed partners with CamDiab on smartphone-based automated insulin delivery

March 22, 2022 By Sean Whooley

Ypsomed CamDiab YpsoPump Dexcom G6

Ypsomed (SWX:YPSN) announced today that it partnered with CamDiab to collaborate on managing automated insulin delivery with a mobile app. The partnership aims to launch CamDiab’s CamAPS FX app for managing glucose levels via insulin pumps using an adaptive, hybrid closed-loop approach, for automated insulin delivery (AID) with Ypsomed’s MyLife YpsoPump system during the first […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: CamDiab, Dexcom, Ypsomed

Lilly and Ypsomed team up on automated insulin delivery

November 19, 2020 By Brian Buntz

Eli Lilly

Eli Lilly (NYSE:LLY) and Ypsomed (SWX:YPSN) are teaming up to create an automated insulin delivery system. Lilly would commercialize the device, which would incorporate an insulin pump from Ypsomed. Burgdorf, Switzerland-based Ypsomed launched its Mylife YpsoPump in Europe in 2016. Now available in 21 countries, the pump includes a touch screen. Lilly plans on commercializing […]

Filed Under: Diabetes, Drug-Device Combinations Tagged With: Eli Lilly & Co., Novo Nordisk, Ypsomed, YpsoPump

Philips’ HealthSuite will track Ypsomed’s connected self-medication devices

October 5, 2018 By Nancy Crotti

  Philips and Ypsomed said today that they will jointly develop a solution for Ypsomed’s new self-medication adherence monitoring services based on Philips’ HealthSuite digital platform. The combination of Ypsomed’s connected devices and Philips’ (NYSE:PHG) cloud-based digital platform will allow Ypsomed’s pharmaceutical customers to deliver value-added services aimed at improving patient outcomes, the companies said in […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Research & Development, Technology, Uncategorized Tagged With: Philips, Ypsomed

Ypsomed to supply Bigfoot with insulin infusion sets for pivotal trial

October 24, 2017 By Sarah Faulkner

Bigfoot, Ypsomed

Ypsomed plans to supply Bigfoot Biomedical with a modified version of its Orbit infusion set for the pivotal trial of Bigfoot’s automated insulin delivery system, the companies said today. Ypsomed’s Orbit infusion sets can be rotated 360°, giving users the freedom to move around, and are fitted using a heat-activated patch. The infusion sets are available with steel or […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Bigfoot Biomedical, Ypsomed

Convenience, compliance & control: How Insulet is changing insulin delivery tech

September 21, 2017 By Sarah Faulkner

Insulet Omnipod

Shacey Petrovic spent nearly a decade trying to convince her diabetic father to switch to an insulin pump, rather than inject himself multiple times each day. But he was wary of the tubing and other challenges that come with constantly wearing a pump. So when Petrovic was tapped to serve as chief commercial officer at Insulet (NSDQ:PODD) in […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Amgen, Bigfoot Biomedical, Eli Lilly & Co., GlaxoSmithKline plc, Insulet, Medtronic, Ypsomed

Insulet, Ypsomed go their separate ways

July 21, 2017 By Sarah Faulkner

Insulet

Ypsomed has been the exclusive distributor of Insulet‘s (NSDQ:PODD) Omnipod insulin management system in Europe since 2010. But today, the companies announced that the arrangement is slated to end on June 30, 2018, after the pair could not agree on extending the contract based on the price set by Insulet, according to Ypsomed. Insulet said […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Insulet, Ypsomed

Seals key in new Ypsomed insulin pump

November 14, 2016 By Sarah Faulkner

Swiss medtech company Ypsomed (SWX:YPSN) launched a portable, light-weight insulin pump with seals designed by Freudenberg Sealing Technologies. The pump, mylife YpsoPump, was introduced into the European market today. Insulin pumps, which continually transport insulin into patients, must have a very precise dosing mechanism. To facilitate a reliable measurement within the pump, there must be as […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Freudenberg Sealing Technologies, Ypsomed

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS